These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14977856)

  • 1. Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma.
    Shaik MS; Chatterjee A; Singh M
    Clin Cancer Res; 2004 Feb; 10(4):1521-9. PubMed ID: 14977856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an aerosolized selective COX-2 inhibitor as a potentiator of doxorubicin in a non-small-cell lung cancer cell line.
    Haynes A; Shaik MS; Chatterjee A; Singh M
    Pharm Res; 2003 Sep; 20(9):1485-95. PubMed ID: 14567645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
    Badawi AF; Eldeen MB; Liu Y; Ross EA; Badr MZ
    Cancer Res; 2004 Feb; 64(3):1181-9. PubMed ID: 14871855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.
    Xin B; Yokoyama Y; Shigeto T; Futagami M; Mizunuma H
    Cancer; 2007 Aug; 110(4):791-800. PubMed ID: 17582802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
    Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
    Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of cyclooxygenase-2 protein during rat hepatocarcinogenesis caused by a choline-deficient, L-amino acid-defined diet and chemopreventive efficacy of a specific inhibitor, nimesulide.
    Denda A; Kitayama W; Murata A; Kishida H; Sasaki Y; Kusuoka O; Tsujiuchi T; Tsutsumi M; Nakae D; Takagi H; Konishi Y
    Carcinogenesis; 2002 Feb; 23(2):245-56. PubMed ID: 11872629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.
    Shaik MS; Chatterjee A; Jackson T; Singh M
    Int J Cancer; 2006 Jan; 118(2):396-404. PubMed ID: 16052515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
    Pang L; Nie M; Corbett L; Knox AJ
    J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of nimesulide and oxaliplatin on tumor growth and lymphatic metastasis of transplanted human lung cancer in nude mice].
    Lang Z; Chen G; Wang DC
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):739-44. PubMed ID: 23291066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors.
    Kusunoki N; Yamazaki R; Kawai S
    Arthritis Rheum; 2002 Dec; 46(12):3159-67. PubMed ID: 12483719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs.
    Steiner AA; Li S; Llanos-Q J; Blatteis CM
    Neuroimmunomodulation; 2001; 9(5):263-75. PubMed ID: 11964521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein.
    Pontsler AV; St Hilaire A; Marathe GK; Zimmerman GA; McIntyre TM
    J Biol Chem; 2002 Apr; 277(15):13029-36. PubMed ID: 11809750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective cyclooxygenase-2 inhibitor nimesulide induces apoptosis in pancreatic cancer cells independent of COX-2.
    Eibl G; Reber HA; Wente MN; Hines OJ
    Pancreas; 2003 Jan; 26(1):33-41. PubMed ID: 12499915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide.
    Shiotani H; Denda A; Yamamoto K; Kitayama W; Endoh T; Sasaki Y; Tsutsumi N; Sugimura M; Konishi Y
    Cancer Res; 2001 Feb; 61(4):1451-6. PubMed ID: 11245450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A COX-2 inhibitor, nimesulide, inhibits chemically-induced rat tongue carcinogenesis through suppression of cell proliferation activity and COX-2 and iNOS expression.
    Yoshida K; Tanaka T; Kohno H; Sakata K; Kawamori T; Mori H; Wakabayashi K
    Histol Histopathol; 2003 Jan; 18(1):39-48. PubMed ID: 12507282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo.
    Liu XH; Kirschenbaum A; Yao S; Lee R; Holland JF; Levine AC
    J Urol; 2000 Sep; 164(3 Pt 1):820-5. PubMed ID: 10953162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model.
    Nam KT; Hahm KB; Oh SY; Yeo M; Han SU; Ahn B; Kim YB; Kang JS; Jang DD; Yang KH; Kim DY
    Clin Cancer Res; 2004 Dec; 10(23):8105-13. PubMed ID: 15585646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.